SAMWHA ELECTRIC, a Leading Manufacturer of Electrolytic Capacitor, Draws Attention in World Electronics Market
24.4.2020 11:00:00 EEST | Business Wire | Press release
SAMWHA ELECTRIC (KRX:009470), a specialty manufacturer of electrolytic capacitors in Korea, attracts attention in the world electronics market by launching a conductive polymer hybrid electrolytic capacitor built on advanced technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200424005097/en/
SAMWHA ELECTRIC, a specialty manufacturer of electrolytic capacitors in Korea, attracts attention in the world electronics market by launching a conductive polymer hybrid electrolytic capacitor built on advanced technology. SAMWHA ELECTRIC has been providing the global market with its electric double layer capacitor ‘Green-Cap’ used for eco-friendly high-valued products, such as 5G, eco-friendly vehicles, medical devices, LED, robots, Internet-of-Things (IoT), and energy storage systems (ESSs) for wind and solar power for many years. Thanks to a long replacement cycle based on fast charge/discharge cycles for over 1 million times, Green-Cap is easy to maintain and it can be used in extreme temperatures. As it does not contain environmentally hazardous substances, it is also easy to treat after use. (Graphic: Business Wire)
SAMWHA ELECTRIC has been providing the global market with its electric double layer capacitor ‘Green-Cap’ used for eco-friendly high-valued products, such as 5G, eco-friendly vehicles, medical devices, LED, robots, Internet-of-Things (IoT), and energy storage systems (ESSs) for wind and solar power for many years.
Thanks to a long replacement cycle based on fast charge/discharge cycles for over 1 million times, Green-Cap is easy to maintain and it can be used in extreme temperatures. As it does not contain environmentally hazardous substances, it is also easy to treat after use.
With increasing demand in strategic markets including electric vehicles, communication, smart consumer electronics, renewable energies, UPS, automotive industry and electronic components, orders for the product is growing worldwide. Through its five sales subsidiaries in Germany, the United States, China, Thailand and India as well as 14 major regional offices in other countries, the company has built stable international business infrastructure to lead the global market.
Expecting brighter future in line with expansion in eco-friendly automotive infrastructure and increase in demand for eco-friendly power due to expanded environment regulation policies, SAMWHA ELECTRIC aims to meet demands for high-specification products by developing high-valued devices at its corporate R&D center and to take an advantageous position while transforming into a leading electronic component company by developing proprietary technologies.
“In order to grow into an integrated electronic parts maker through systematic quality control, we are implementing management systems in three stages, and effectively managing production processes with enterprise resource planning (ERP), a real-time data management system, and manufacturing execution system (MES),” said a manager at SAMWHA ELECTRIC.
Backed by these efforts, SAMWHA ELECTRIC is further advancing into the global market with synergies of designation as one of beneficiaries of support program of the Korea Trade-Investment Promotion Agency (KOTRA). The company also values shared growth with affiliates by establishing partnership relations. The corporate culture of SAMWHA ELECTRIC that shares values with clients has potential for further development with their trust.
Products by SAMWHA ELECTRIC
- EDLC (Electric Double Layer Capacitor) for Radial, Snap-in, Axial Type & Module
- Conductive Polymer Hybrid Aluminum Electrolytic Capacitor for Radial, SMD Type
- Aluminum Electrolytic Capacitor for Radial, SMD, Snap-in, Lug, Screw Type
Main Application
- Household Appliance for High Ripple Current, Miniaturization and Long Life
- Solar Power Inverter for High Voltage, High Capacitance and High Ripple Current
- Power Electronics for High Capacitance, High Ripple Current and Long Life and Power Industry, Plant Business, Infrastructure Business Segment
- Led Lighting for Ultra-High Temperature, Long Life and Low Impedance
- Automotive for powertrain (ECU, DC/DC Converter), Safety (Breaking, Airbag, ABS) and Exterior (LED Headlight)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200424005097/en/
Contact information
SAMWHA Electric H.Q.
Mr. Yong Dong Kim
+82-2-2056-1646
sesale1@samwha.com
SAMWHA EUROPE GmbH
Mr. Kwang Hyun Park
+49-0-69-9637-65-0
europe@samwha.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 11:11:00 EEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 09:00:00 EEST | Press release
Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521069859/en/ Boomi Named One of The Sunday Times Best Places to Work 2026 Boomi's results speak to a workplace culture that goes well beyond industry norms. The company achieved an average employee happiness score of 86%, rated Excellent, with consistent scores across all six dimensions of WorkL's framework. Most strikingly, Boomi's flight risk, the proportion of employees who may be considering leaving, stood at just 3%, against a technology se
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 08:09:00 EEST | Press release
LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through centers in Romania and Portugal. This would create a more diversified portfolio for LTM – expanding its scale in Europe and Australia, enhancing its position in regulated and high-growth verticals through marquee customer relationships. The deal would augment LTM’s global AI-centric capabilities with local domain and near-shore expertise crucial for delivering digital an
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 08:00:00 EEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom